Sellas Life Sciences Group

SLS · NASDAQ

$11.98+$1.49 (+14.20%)TodayMarket closed ·
Prev close $10.49

Who owns SLS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 27.3% of SLS’s shares.

  • BlackRock Institutional Trust Company, N.A.6.9%
  • State Street Investment Management (US)6.6%
  • Vanguard Capital Management, LLC4.2%
  • Geode Capital Management, L.L.C.2.5%
  • Next 6 largest institutions7.1%
  • All other shareholders72.7%
Top institutional holders of SLS
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.13.53M6.88%
State Street Investment Management (US)13.00M6.61%
Vanguard Capital Management, LLC8.23M4.18%
Geode Capital Management, L.L.C.4.88M2.48%
Anson Funds Management LP.4.50M2.29%
Edward Jones2.30M1.17%
Vanguard Portfolio Management, LLC2.16M1.10%
Susquehanna International Group, LLP2.05M1.04%
Northern Trust Investments, Inc.1.56M0.79%
Stergiou (Angelos M)1.38M0.70%

Largest mutual fund holders

Top mutual fund holders of SLS
HolderShares% of shares
State Street SPDR S&P Biotech ETF9.12M4.64%
Vanguard Total Stock Market Index Fund5.93M3.02%
iShares Russell 2000 ETF4.91M2.50%
Vanguard Extended Market Index Fund2.15M1.09%
Fidelity Small Cap Index Fund2.05M1.04%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of SLS in the last 6 months.

Latest SLS insider transactions
InsiderTypeSharesValue
Stergiou Angelos M.Award1.06M—

Short interest

Settled Sep 30, 2026

Shares short
55.13M
Days to cover
9.45
% of shares outstanding
28.04%
Average daily volume
5.84M
Change since last report
−6.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.